Skip to main content
Top
Published in: European Journal of Pediatrics 11/2010

01-11-2010 | Short Report

Fibrodysplasia ossificans progressiva (FOP): watch the great toes!

Authors: Mutlu Kartal-Kaess, Eileen M. Shore, Meiqi Xu, Ludwig Schwering, Markus Uhl, Rudolf Korinthenberg, Charlotte Niemeyer, Frederick S. Kaplan, Melchior Lauten

Published in: European Journal of Pediatrics | Issue 11/2010

Login to get access

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder and the most disabling condition of heterotopic (extraskeletal) ossification in humans. Extraskeletal bone formation associated with inflammation preceding the osseous conversion usually begins in the first decade, predominantly in the head, neck, and shoulders. All patients have malformed great toes. Most patients have a spontaneous mutation of the ACVR1 gene. We report a 17-year-old girl with malformed great toes who had her first episode of heterotopic ossification and impaired mobility of the left hip at the age of 13 years. No inflammatory fibroproliferative masses preceded the onset of heterotopic ossification. Radiographic studies demonstrated myositis ossificans, but failure to associate the great toe malformation with heterotopic ossification led to a failure to diagnose FOP. She underwent repeated and unnecessary operative procedures to remove a recurrent lesion. FOP was finally suspected when the great toe malformation was correlated with the trauma-induced heterotopic ossification. Genetic analysis confirmed the presence of the classic FOP mutation (ACVR1 c.617G>A; R206H). This case highlights the importance of examining the great toes in anyone with heterotopic ossification. The association of malformations of the great toe with heterotopic ossification in all cases of classic FOP will lead to prompt clinical diagnosis and the prevention of iatrogenic harm.
Literature
2.
go back to reference Cohen RB, Hahn GV, Tabas JA et al (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Joint Surg Am 75:215–219PubMed Cohen RB, Hahn GV, Tabas JA et al (1993) The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J Bone Joint Surg Am 75:215–219PubMed
3.
go back to reference Connor JM, Evans DA (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64:76–83PubMed Connor JM, Evans DA (1982) Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64:76–83PubMed
4.
go back to reference Deirmengian GK, Hebela NM, O’Connell M et al (2008) Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 90:366–374CrossRefPubMed Deirmengian GK, Hebela NM, O’Connell M et al (2008) Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 90:366–374CrossRefPubMed
5.
go back to reference Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol 3:243–250CrossRef Glaser DL, Kaplan FS (2005) Treatment considerations for the management of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol 3:243–250CrossRef
6.
go back to reference Glaser DL, Rocke DM, Kaplan FS (1998) Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 346:110–116CrossRefPubMed Glaser DL, Rocke DM, Kaplan FS (1998) Catastrophic falls in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 346:110–116CrossRefPubMed
7.
go back to reference Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2007) A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther 7:705–712CrossRefPubMed Kaplan FS, Glaser DL, Pignolo RJ, Shore EM (2007) A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther 7:705–712CrossRefPubMed
8.
go back to reference Kaplan FS, Glaser DL, Shore EM et al (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol 3:183–188CrossRef Kaplan FS, Glaser DL, Shore EM et al (2005) The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol 3:183–188CrossRef
9.
go back to reference Kaplan FS, Glaser DL, Shore EM et al (2007) Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89:347–357CrossRefPubMed Kaplan FS, Glaser DL, Shore EM et al (2007) Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89:347–357CrossRefPubMed
10.
go back to reference Kaplan FS, Groppe J, Pignolo RJ, Shore EM (2007) Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci 1116:113–133CrossRefPubMed Kaplan FS, Groppe J, Pignolo RJ, Shore EM (2007) Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci 1116:113–133CrossRefPubMed
11.
go back to reference Kaplan FS, Le Merrer M, Glaser DL et al (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191–205CrossRefPubMed Kaplan FS, Le Merrer M, Glaser DL et al (2008) Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 22:191–205CrossRefPubMed
12.
go back to reference Kaplan FS, Shore EM (2008) Fibrodysplasia (myositis) ossificans progressiva. In: Rosen CS (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. The American Society for Bone and Mineral Research, Lippincott-Raven, Philadelphia, pp 442–444 Kaplan FS, Shore EM (2008) Fibrodysplasia (myositis) ossificans progressiva. In: Rosen CS (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. The American Society for Bone and Mineral Research, Lippincott-Raven, Philadelphia, pp 442–444
13.
go back to reference Kaplan FS, Shore EM, Connor JM (2002) Fibrodysplasia ossificans progressiva. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders: molecular, genetic, and medical aspects, 2nd edn. Wiley-Liss, New York, pp 827–840 Kaplan FS, Shore EM, Connor JM (2002) Fibrodysplasia ossificans progressiva. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders: molecular, genetic, and medical aspects, 2nd edn. Wiley-Liss, New York, pp 827–840
14.
go back to reference Kaplan FS, Tabas JA, Gannon FH et al (1993) The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Joint Surg Am 75:220–230PubMed Kaplan FS, Tabas JA, Gannon FH et al (1993) The histopathology of fibrodysplasia ossificans progressiva. An endochondral process. J Bone Joint Surg Am 75:220–230PubMed
15.
go back to reference Kaplan FS, Xu M, Glaser DL et al (2008) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 121:e1295–e1300CrossRefPubMed Kaplan FS, Xu M, Glaser DL et al (2008) Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 121:e1295–e1300CrossRefPubMed
16.
go back to reference Kaplan FS, Xu M, Seemann P, Connor JM et al (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30:379–390CrossRefPubMed Kaplan FS, Xu M, Seemann P, Connor JM et al (2009) Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 30:379–390CrossRefPubMed
17.
go back to reference Kitterman JA, Kantanie S, Rocke DM, Kaplan FS (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 116:e654–e661CrossRefPubMed Kitterman JA, Kantanie S, Rocke DM, Kaplan FS (2005) Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 116:e654–e661CrossRefPubMed
18.
go back to reference Lanchoney TF, Cohen RB, Rocke DM et al (1995) Permanent heterotopic ossification at the injection site after diphtheria–tetanus–pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr 126:762–764CrossRefPubMed Lanchoney TF, Cohen RB, Rocke DM et al (1995) Permanent heterotopic ossification at the injection site after diphtheria–tetanus–pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr 126:762–764CrossRefPubMed
19.
go back to reference McKusick VA (2010) Heritable disorders of connective tissue. Mosby, St Louis, MO McKusick VA (2010) Heritable disorders of connective tissue. Mosby, St Louis, MO
20.
go back to reference Rocke DM, Zasloff M, Peeper J et al (1994) Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 301:243–248PubMed Rocke DM, Zasloff M, Peeper J et al (1994) Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 301:243–248PubMed
21.
go back to reference Scarlett RF, Rocke DM, Kantanie S et al (2004) Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 423:275–279CrossRefPubMed Scarlett RF, Rocke DM, Kantanie S et al (2004) Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res 423:275–279CrossRefPubMed
22.
go back to reference Schaffer AA, Kaplan FS, Tracy MR et al (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel–Feil syndrome: clues from the BMP signaling pathway. Spine (Phila Pa 1976) 30:1379–1385 Schaffer AA, Kaplan FS, Tracy MR et al (2005) Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel–Feil syndrome: clues from the BMP signaling pathway. Spine (Phila Pa 1976) 30:1379–1385
23.
go back to reference Shen Q, Little SC, Xu M et al (2009) The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest 119:3462–3472PubMed Shen Q, Little SC, Xu M et al (2009) The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest 119:3462–3472PubMed
24.
go back to reference Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol 3:201–204CrossRef Shore EM, Feldman GJ, Xu M, Kaplan FS (2005) The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol 3:201–204CrossRef
25.
go back to reference Shore EM, Kaplan FS (2008) Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 43:427–433CrossRefPubMed Shore EM, Kaplan FS (2008) Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 43:427–433CrossRefPubMed
26.
go back to reference Shore EM, Xu M, Feldman GJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527CrossRefPubMed Shore EM, Xu M, Feldman GJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527CrossRefPubMed
27.
go back to reference Yu PB, Deng DY, Lai CS et al (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14:1363–1369CrossRefPubMed Yu PB, Deng DY, Lai CS et al (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14:1363–1369CrossRefPubMed
Metadata
Title
Fibrodysplasia ossificans progressiva (FOP): watch the great toes!
Authors
Mutlu Kartal-Kaess
Eileen M. Shore
Meiqi Xu
Ludwig Schwering
Markus Uhl
Rudolf Korinthenberg
Charlotte Niemeyer
Frederick S. Kaplan
Melchior Lauten
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 11/2010
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-010-1232-5

Other articles of this Issue 11/2010

European Journal of Pediatrics 11/2010 Go to the issue